The Scientific Research Team at Oric Pharmaceuticals focuses on elucidating the mechanisms of cancer therapy resistance and developing innovative treatments to counteract these mechanisms. This team conducts advanced preclinical and clinical research, including in vivo pharmacology, bioinformatics analyses, and medicinal chemistry, to support the discovery and optimization of novel oncology therapeutics. Their efforts are crucial in advancing ORIC’s lead assets, such as ORIC-101, and expanding the company's pipeline of resistance-targeting cancer treatments.
Amber Wang
Senior Bioinformatics Scientis...
Bob Warne
Senior Principal Scientist
Brian Blank
Principal Scientist
Chelsea Chen
Scientist
Christopher Weber
Senior Scientist
Claire Repellin
Principal Scientist
Danial Barati
In Vivo Pharmacology Research ...
Daniel Holycross
Scientist, Process Chemistry
Daniel Shore
Senior Scientist, Medicinal Ch...
Dena Sutimantanapi
Senior Research Associate
Denisse Carvajal Mal...
Scientist
Idil Ulengin-Talkish
Senior Scientist
Jared Moore
Associate Director, Medicinal ...
Jason B.
Sr. Principal Scientist
Joanna Wang
Formulation Sr. Scientist
Krista Bowman
Sr. Principle Scientist
Kyle Edgar
Staff Scientist
Livia Ulicna
Translational Medicine Scienti...
Michal Pawlak
Senior Bioinformatics Contract...
Rakesh Vekariya
Senior Scientist, Medicinal Ch...
Siobhan K. McRee
Scientist
Subhash Katewa
Senior Principal Scientist, Tr...
View all